Venous sinus thrombosis in traumatic brain injury: a major trauma centre experience

2021 ◽  
Author(s):  
Lauren Harris ◽  
Dominic Townsend ◽  
Rose Ingleton ◽  
Alice Kershberg ◽  
Chris Uff ◽  
...  
Keyword(s):  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Major Trauma ◽  
Sinus Thrombosis ◽  
Trauma Centre ◽  
Venous Sinus ◽  
Venous Sinus Thrombosis ◽  
Major Trauma Centre

scholarly journals Validation of the Simplified Motor Score in patients with traumatic brain injury at a major trauma centre in South Africa

2018 ◽  
Vol 108 (2) ◽  
pp. 90
Author(s):  
J J P Buitendag ◽  
A Ras ◽  
V Y Kong ◽  
J L Bruce ◽  
G L Laing ◽  
...  
Keyword(s):  
South Africa ◽  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Major Trauma ◽  
Trauma Centre ◽  
Motor Score ◽  
Major Trauma Centre

scholarly journals Validation of the Simplified Motor Score in patients with traumatic brain injury at a major trauma centre in South Africa

2018 ◽  
Vol 108 (2) ◽  
pp. 90 ◽  
Author(s):  
J J P Buitendag ◽  
A Ras ◽  
V Y Kong ◽  
J L Bruce ◽  
G L Laing ◽  
...  
Keyword(s):  
South Africa ◽  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Major Trauma ◽  
Trauma Centre ◽  
Motor Score ◽  
Major Trauma Centre

P22 Phenytoin versus levetiracetam for post traumatic brain injury seizure prophylaxis; a retrospective study at a UK major trauma centre

2019 ◽  
Vol 90 (3) ◽  
pp. e31.2-e31
Author(s):  
L Harris ◽  
S Hateley ◽  
B Seemungal
Keyword(s):  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Length Of Stay ◽  
Major Trauma ◽  
Average Length ◽  
Study Data ◽  
Trauma Centre ◽  
Seizure Prophylaxis ◽  
Major Trauma Centre ◽  
The Impact

Objectives12% of patients with severe Traumatic brain injury (TBI) suffer from seizures. Evidence suggests that the use of an antiepileptic drug (AED) is beneficial in preventing early post TBI seizures. To date, no specific NICE guidelines exist on the choice of post TBI seizure prophylaxis. This study aims to identify the trend in AED usage, the impact on length of stay and to compare the tolerability of phenytoin and levetiracetam.DesignRetrospective observational study.Subjects201 patients.MethodsAll patients admitted to a Major Trauma Unit following a head injury treated with levetiracetam or phenytoin for seizure prophylaxis were included in the study. Data was collected between October 2013 – September 2014 and November 2016 – October 2017. Patient demographics, Glasgow Coma Score (GCS) on admission, length of treatment, AED toxicity, length of stay, complications, surgical input and length of ITU stay were recorded.Results85.6% of patients were treated with phenytoin in 2013–2014% and 82.5% were treated with levetiracetam in 2016–2017. The average length of stay for phenytoin was 23.2 days and 13.9 days for levetiracetam. Subgroup analysis was performed on patients with an admission GCS of 14–15. Length of stay for phenytoin was 14.9 days (SD −11.87) and levetiracetam 9.4 days (SD 10.588) (p=0.07). 24% of patients on phenytoin and 14% on levetiracetam suffered from dizziness.ConclusionsThis suggests that levetiracetam is tolerated better with fewer side effects. We recommend its use in clinical practice.

Long-term prognosis of cerebral venous sinus thrombosis in childhood

2004 ◽  
Vol 46 (08) ◽  
Author(s):  
Els LLM De Schryver ◽  
Ingrid Blom ◽  
Kees PJ Braun ◽  
L Jaap Kappelle ◽  
Gabriël JE Rinkel ◽  
...  
Keyword(s):  
Sinus Thrombosis ◽  
Cerebral Venous Sinus Thrombosis ◽  
Venous Sinus ◽  
Venous Sinus Thrombosis ◽  
Long Term Prognosis

MR Findings of Carebrai Venous Sinus Thrombosis

1994 ◽  
Vol 31 (4) ◽  
pp. 627
Author(s):  
Moon Hee Han ◽  
Choong Gon Choi ◽  
Kee Chang ◽  
Myung Kwan Lim
Keyword(s):  
Sinus Thrombosis ◽  
Venous Sinus ◽  
Venous Sinus Thrombosis
Sign in / Sign up

Export Citation Format

Share Document